Imaging characterization of non-hypersecreting adrenal masses. Comparison between MR and radionuclide techniques(350 views)(PDF public247 views) Maurea S, Caracò C, Klain M, Mainolfi C, Salvatore M
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2004; 48(3): 188-197.
Div. of Radiology/Nuclear Medicine, Dept. of Biomorphol./Funct. Sciences, Federico II University of Naples, Naples, Italy
Institute of Biostructures/Bioimages, National Council for Researches, Naples, Italy
Via Raffaele De Cesare 7, 80132 Napoli, Italy
Gross, M.D., Shapiro, B., Clinical review 50. Clinical silent adrenal masses (1993) J. Clin. Endocrinol. Metab., 77, pp. 885-888
Ross, M.S., Aron, D.C., Hormonal evaluation of the patient with an incidentally discovered adrenal mass (1990) N. Engl. J. Med., 323, pp. 1402-1405
Mayo-Smith, W.W., Boland, G.W., Noto, R.B., Lee, M., State-of-the-art adrenal imaging (2001) Radiographics, 21, pp. 995-1012
Korobkin, M., Brodeur, F.J., Francis, I.R., Quint, L.E., Dunnik, N.R., Londy, F., CT time-attenuation washout curves of adrenal adenomas and nonadenomas (1998) Am. J. Roentgenol., 170, pp. 747-752
Heinz-Peer, G., Honigschnabl, S., Schneider, B., Niederle, B., Kaserer, K., Lechner, G., Characterization of adrenal masses using MR imaging with histopathologic correlation (1999) Am. J. Roentgenol., 173, pp. 15-22
Francis, I.R., Gross, M.D., Shapiro, B., Korobkin, M., Quint, L.E., Integrated imaging of adrenal disease (1992) Radiology, 184, pp. 1-13
Falke, T.H.M., Sandler, M.P., Classification of silent adrenal masses: Time to get practical (1994) J. Nucl. Med., 35, pp. 1152-1154
Lawson, M.A., Role of molecular imaging in management of nonhypersecreting adrenal masses (2001) J. Nucl. Med., 42, pp. 893-894
Maurea, S., Klain, M., Mainolfi, C., Ziviello, M., Salvatore, M., The diagnostic role of radionuclide imaging in the evaluation of patients with non-hypersecreting adrenal masses (2001) J. Nucl. Med., 42, pp. 884-892
Truong, B., Jolles, P.R., Mullaney, J.M., Primary adrenal lymphoma: Gallium scintigraphy and correlative imaging (1997) J. Nucl. Med., 38, pp. 1770-1771
Shulkin, B.L., Wieland, D.M., Schwaiger, M., Thompson, N.W., Francis, I.R., Haka, M.S., PET scanning with hydroxyephedrine: An approach to the localization of pheochromocytoma (1992) J. Nucl. Med., 33, pp. 1125-1131
Boland, G.W., Goldberg, M.A., Lee, M.J., Mayo-Smith, W.W., Dixon, J., McNicholas, M.M., Indeterminate adrenal mass in patients with cancer: Evaluation at PET with 2-[F-18]-fluoro-2-deoxy-D-glucose (1995) Radiology, 194, pp. 131-134
Erasmus, J.J., Patz, E.F., McAdams, H.P., Murray, J.G., Herndon, J., Coleman, R.E., Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F fluorodeoxyglucose positron emission tomography (1997) AJR Am. J. Roentgenol., 168, pp. 1357-1360
Maurea, S., Mainolfi, C., Bazzicalupo, L., Panico, M.R., Imparato, C., Alfano, B., Imaging of adrenal tumors using FDG PET: Comparison of benign and malignant lesions (1999) AJR Am. J. Roentgenol., 173, pp. 25-29
Bergstrom, M., Juhlin, C., Bonasera, T.A., Sundin, A., Rastad, J., Akerstrom, G., PET imaging of adrenal cortical tumors with the 11betahydroxylase tracer C-11 metomidate (2000) J. Nucl. Med., 41, pp. 275-282
Maurea, S., Lastoria, S., Caraco, C., Klain, M., Varrella, P., Acampa, W., The role of radiolabeled somatostatin analogs in adrenal imaging (1996) Nucl. Med. Biol., 23, pp. 677-680
Slapa, R.Z., Jakubowski, W., Januszewicz, A., Kasperlik-Zaluska, A.A., Dabrovska, E., Fijuth, J., Discriminatory power of MRI for differentiation of adrenal non-adenomas vs adenomas evaluated by means of ROC analysis: Can biopsy be obviated? (2000) Eur. Radiol., 10, pp. 95-104
Caoili, E.M., Korobkin, M., Francis, I.R., Cohan, R.H., Platt, J.F., Dunnick, N.R., Adrenal masses: Characterization with combined unenhanced and delayed enhanced CT (2002) Radiology, 222, pp. 629-633
Barzon, L., Scaroni, C., Sonino, N., Fallo, F., Gregianin, M., Macri, C., Incidentally discovered adrenal tumors: Endocrine and scintigraphic correlates (1998) J. Clin. Endocrinol. Metab., 83, pp. 55-62
Maurea, S., Caracò, C., Castelli, L., Filice, S., Alfano, B., Ruffolo, F., La risonanza magnetica nello studio delle neoplasie surrenaliche: Analisi qualitativa e quantitativa dell'intensità di segnale (1998) Radiol. Med., 95, pp. 199-207
Young, W.F., Management approaches to adrenal incidentalomas: A view from Rochester, Minnesota (2000) Endocrinol. Metab. Clin. North Am., 29, pp. 159-185
Schteingart, D.E., Management approaches to adrenal incidentalomas: A view from Ann Arbor, Michigan (2000) Endocrinol. Metab. Clin. North Am., 29, pp. 127-139
Kloos, R. T., Gross, M. D., Francis, I. R., Korobkin, M., Shapiro, B., Incidentally discovered adrenal masses (1995) Endocr. Rev., 16, pp. 460-48
Gross, M. D., Shapiro, B., Clinical review 50. Clinical silent adrenal masses (1993) J. Clin. Endocrinol. Metab., 77, pp. 885-888
Ross, M. S., Aron, D. C., Hormonal evaluation of the patient with an incidentally discovered adrenal mass (1990) N. Engl. J. Med., 323, pp. 1402-1405
Mayo-Smith, W. W., Boland, G. W., Noto, R. B., Lee, M., State-of-the-art adrenal imaging (2001) Radiographics, 21, pp. 995-1012
Francis, I. R., Gross, M. D., Shapiro, B., Korobkin, M., Quint, L. E., Integrated imaging of adrenal disease (1992) Radiology, 184, pp. 1-13
Falke, T. H. M., Sandler, M. P., Classification of silent adrenal masses: Time to get practical (1994) J. Nucl. Med., 35, pp. 1152-1154
Lawson, M. A., Role of molecular imaging in management of nonhypersecreting adrenal masses (2001) J. Nucl. Med., 42, pp. 893-894
Shulkin, B. L., Wieland, D. M., Schwaiger, M., Thompson, N. W., Francis, I. R., Haka, M. S., PET scanning with hydroxyephedrine: An approach to the localization of pheochromocytoma (1992) J. Nucl. Med., 33, pp. 1125-1131
Boland, G. W., Goldberg, M. A., Lee, M. J., Mayo-Smith, W. W., Dixon, J., McNicholas, M. M., Indeterminate adrenal mass in patients with cancer: Evaluation at PET with 2- [F-18] -fluoro-2-deoxy-D-glucose (1995) Radiology, 194, pp. 131-134
Erasmus, J. J., Patz, E. F., McAdams, H. P., Murray, J. G., Herndon, J., Coleman, R. E., Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F fluorodeoxyglucose positron emission tomography (1997) AJR Am. J. Roentgenol., 168, pp. 1357-1360
Slapa, R. Z., Jakubowski, W., Januszewicz, A., Kasperlik-Zaluska, A. A., Dabrovska, E., Fijuth, J., Discriminatory power of MRI for differentiation of adrenal non-adenomas vs adenomas evaluated by means of ROC analysis: Can biopsy be obviated? (2000) Eur. Radiol., 10, pp. 95-104
Caoili, E. M., Korobkin, M., Francis, I. R., Cohan, R. H., Platt, J. F., Dunnick, N. R., Adrenal masses: Characterization with combined unenhanced and delayed enhanced CT (2002) Radiology, 222, pp. 629-633
Maurea, S., Carac, C., Castelli, L., Filice, S., Alfano, B., Ruffolo, F., La risonanza magnetica nello studio delle neoplasie surrenaliche: Analisi qualitativa e quantitativa dell'Intensit di segnale (1998) Radiol. Med., 95, pp. 199-207
Young, W. F., Management approaches to adrenal incidentalomas: A view from Rochester, Minnesota (2000) Endocrinol. Metab. Clin. North Am., 29, pp. 159-185
Schteingart, D. E., Management approaches to adrenal incidentalomas: A view from Ann Arbor, Michigan (2000) Endocrinol. Metab. Clin. North Am., 29, pp. 127-139
Imaging characterization of non-hypersecreting adrenal masses. Comparison between MR and radionuclide techniques
Aim. In patients with non-hypersecreting adrenal masses, tumor characterization is clinically relevant to establish the appropriate treatment planning. The aim of this study was to comparatively characterize such adrenal lesions using MR and radionuclide techniques. Methods. Thirty patients with non-hypersecreting unilateral adrenal tumors underwent both MR and adrenal scintigraphy. MR was performed using SE T1- (pre- and post-gadolinium DTPA) and T2-weighted images as well as in- and out-phase chemical-shift imaging (CSI). MR qualitative and quantitative (signal intensity ratios) evaluation was performed. Radionuclide studies consisted of iodine-131 nor-cholesterol (n=20), iodine-131 MIBG (n=15) and fluorine-18 FDG PET (n=11) scans. Histology (n=16), biopsy (n=3) or clinical-imaging follow-up (n=11) demonstrated 13 adenomas, 3 cysts, 2 myelolipomas, 4 pheochromocytomas (pheos), 4 carcinomas, 1 sarcoma and 3 metastases. Comparative imaging analysis was focused on adenomas, pheos and malignant tumors. Results. Qualitative MR evaluation showed: signal T2-hyperintensity in 46% of adenomas and in 100% of pheos and malignant tumors, no gadolinium enhancement in 92% of adenomas and definite signal intensity loss on CSI in 100% of such tumor lesions, gadolinium enhancement in 100% of pheos and in 63% of malignancies and no absolute change of signal intensity on CSI in 100% of both pheos and malignancies. Quantitative MR analysis demonstrated: significantly higher signal T2-hyperintensity of pheos compared to adenomas and malignancies as well as significantly higher enhancement after gadolinium in pheos compared to adenomas and malignancies (P
Imaging characterization of non-hypersecreting adrenal masses. Comparison between MR and radionuclide techniques
No results.
Imaging characterization of non-hypersecreting adrenal masses. Comparison between MR and radionuclide techniques
Antonini A, Vitale C, Barone P, Cilia R, Righini A, Bonuccelli U, Abbruzzese G, Ramat S, Petrone A, Quatrale R, Marconi R, Ceravolo R, Stefani A, Lopiano L, Zappia M, Capus L, Morgante L, Tamma F, Tinazzi M, Colosimo C, Guerra UP, Valzania F, Fagioli G, Distefano A, Bagnato A, Feggi L, Anna S, Maria Teresa Rosaria De Cr, Nobili F, Mazzuca N, Baldari S, Eleopra R, Bestetti A, Benti R, Varrone A, Volterrani D, Massa R, Stocchi F, Schillaci O, Dore F, Zibetti M, Castellano G, Battista SG, Giorgetti G * The relationship between cerebral vascular disease and parkinsonism: The VADO study(496 views) Parkinsonism Relat D (ISSN: 1353-8020, 1873-5126, 1873-5126electronic), 2012; 18(6): 775-780. Impact Factor:3.274 ViewExport to BibTeXExport to EndNote
Malvindi MA, Greco A, Conversano F, Figuerola A, Corti M, Bonora M, Lascialfari A, Doumari HA, Moscardini M, Cingolani R, Gigli G, Casciaro S, Pellegrino T, Ragusa A * MR Contrast Agents(292 views) Small Animal Imaging, 2011 Jul 8; 21(13): 2548-2555. Impact Factor:1.784 ViewExport to BibTeXExport to EndNote
Ntziachristos V, Cuénod CA, Fournier L, Balvay D, Pradel C, Siauve N, Clement O, Jouannot E, Lucidarme O, Vecchio SD, Salvatore M, Law B, Tung C-H, Jain RK, Fukumura D, Munn LL, Brown EB, Schellenberger E, Montet X, Weissleder R, Clerck ND, Postnov A * Tumor Imaging(350 views) Textbook Of In Vivo Imaging In Vertebrates (ISSN: 9780-4700), 2007 Jul 16; 1: 277-309. Impact Factor:1.148 ViewExport to BibTeXExport to EndNote
Hesse B, Tagil K, Cuocolo A, Anagnostopoulos C, Bardies M, Bax J, Bengel F, Busemann Sokole E, Davies G, Dondi M, Edenbrandt L, Franken P, Kjaer A, Knuuti J, Lassmann M, Ljungberg M, Marcassa C, Marie PY, Mckiddie F, O'connor M, Prvuolovich E, Underwood R * 3. 0 T perfusion MR imaging(726 views) Rivista Di Neuroradiologia (ISSN: 1120-9976), 2004; 17(6): 807-812. Impact Factor:0.023 ViewExport to BibTeXExport to EndNote